Explore more publications!

Bangladesh Health Times Press Releases

Labels On
Left-wing Center-left Neutral Public Broadcaster Gov't Institution Center-right Right-wing Pro-Government Gov't Propaganda Indeterminate
Info
UN Refugee Chief Urges Increased Aid to Myanmar Minorities

UN Refugee Chief Urges Increased Aid to Myanmar Minorities

NY's Galleria on Third Launches New Artwork Collection and Benefit Art Show
Alvotech’s Lenders Lower Interest on Senior Secured Term Loan Facility
Asia Pacific Fertilizers Market Size to Worth USD 313.44 Billion by 2034
WHO Says Rubella Eliminated in Nepal

WHO Says Rubella Eliminated in Nepal

Alvotech Announces Webcast to Report Financial Results for the First Half of 2025 on August 14, 2025, at 8:00 am EDT
Eveliqure Announces Dosing of First Participants in a Phase 2b study of the ShigETEC Vaccine in Shigellosis
Alvotech’s Private Placement Completed with Delivery of SDRs and Shares to Investors
OPEC Fund mobilizes over US$1 billion to advance sustainable development
Alvotech and Dr. Reddy’s Enter into Collaboration to Co-Develop Biosimilar Candidate to Keytruda® (pembrolizumab)
Global Influencer, Model, and Endo Advocate, Katya Karlova Throws Support Behind Never Give Up Day
Governor Hochul Was a Guest on ‘Up Close With Bill Ritter’

Governor Hochul Was a Guest on ‘Up Close With Bill Ritter’

Autolus Therapeutics Announces Positive CHMP Opinion for Obecabtagene Autoleucel for Adult Patients (age 26 and older) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)
D’Art Accomplishes a Milestone of 60,000 Retail Touchpoints Across Diverse Markets
Annual Report Shows Helpster Doubling Impact in Fight Against Maternal and Child Mortality
Global NGO Splash Receives Transformative $40 Million Investment to Expand Support to African Schools
WHO Cautions Chikungunya Spread Threatens Billions

WHO Cautions Chikungunya Spread Threatens Billions

Alvotech Announces Webcast of First Quarter 2025 Financial Results on May 8, 2025, at 8:00 am EDT
Autolus Therapeutics Announces License of AUCATZYL® (obecabtagene autoleucel) Issued by UK MHRA for Adult Patients (≥ 18 years) with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (R/R B-ALL)(1)
Agricultural Innovators Recognized as DialogueNEXT Conference Charts a Path for the Future of Food Production

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions